TW201343174A - 治療代謝失調組合物 - Google Patents

治療代謝失調組合物 Download PDF

Info

Publication number
TW201343174A
TW201343174A TW102114264A TW102114264A TW201343174A TW 201343174 A TW201343174 A TW 201343174A TW 102114264 A TW102114264 A TW 102114264A TW 102114264 A TW102114264 A TW 102114264A TW 201343174 A TW201343174 A TW 201343174A
Authority
TW
Taiwan
Prior art keywords
extract
composition
plant
treatment
metabolic
Prior art date
Application number
TW102114264A
Other languages
English (en)
Chinese (zh)
Inventor
阿凡德 薩克蘭尼
尼萊許 馬爾普瑞
帕里克希特 蓋克瓦德
薩提許 納姆迪歐 薩瓦特
圖卡蘭 奇桑諾 馬內
索梅許 夏爾瑪
Original Assignee
皮拉馬爾企業有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 皮拉馬爾企業有限公司 filed Critical 皮拉馬爾企業有限公司
Publication of TW201343174A publication Critical patent/TW201343174A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW102114264A 2012-04-23 2013-04-22 治療代謝失調組合物 TW201343174A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261636792P 2012-04-23 2012-04-23

Publications (1)

Publication Number Publication Date
TW201343174A true TW201343174A (zh) 2013-11-01

Family

ID=49482298

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102114264A TW201343174A (zh) 2012-04-23 2013-04-22 治療代謝失調組合物

Country Status (16)

Country Link
US (1) US20150290265A1 (enExample)
EP (1) EP2841080A4 (enExample)
JP (1) JP2015514797A (enExample)
KR (1) KR20150003862A (enExample)
CN (1) CN104244962A (enExample)
AU (1) AU2013254329A1 (enExample)
BR (1) BR112014026326A2 (enExample)
CA (1) CA2870907A1 (enExample)
IL (1) IL235317A0 (enExample)
IN (1) IN2014MN02269A (enExample)
MX (1) MX2014012742A (enExample)
NZ (1) NZ701133A (enExample)
RU (1) RU2014145931A (enExample)
SA (1) SA113340494B1 (enExample)
TW (1) TW201343174A (enExample)
WO (1) WO2013160811A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3233188A4 (en) * 2014-12-19 2018-11-07 Halo Life Science, LLC Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels
EP3529245A4 (en) 2016-10-24 2020-12-23 Yumanity Therapeutics, Inc. COMPOUNDS AND USES OF THE LATEST
MA47212A (fr) 2017-01-06 2019-11-13 Yumanity Therapeutics Inc Méthodes de traitement de troubles neurologiques
WO2019084157A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. COMPOUNDS AND USES THEREOF
MX2020007394A (es) 2018-01-10 2020-09-03 Brightseed Inc Metodo para modular el metabolismo.
ES3043183T3 (en) 2018-03-23 2025-11-25 Janssen Pharmaceutica Nv Compounds and uses thereof
MA54829A (fr) 2019-01-24 2021-12-01 Yumanity Therapeutics Inc Composés et leurs utilisations
KR20220100896A (ko) 2019-11-11 2022-07-18 브라이트씨드, 인크. 추출물, 소모가능 생성물 및 추출물에서 생물활성 대사산물을 농후화하는 방법
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
KR102408566B1 (ko) * 2020-04-09 2022-06-16 대한민국 터미날리아 비아라타 추출물을 이용한 피부 주름 개선용 조성물
JP2023144436A (ja) * 2022-03-28 2023-10-11 住友化学株式会社 エラグ酸含有組成物の製造方法及びエラグ酸含有組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053864A (ja) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk 糖尿病疾患予防・治療剤
JP2006188486A (ja) * 2004-12-07 2006-07-20 Toyo Shinyaku:Kk 体脂肪蓄積抑制または低減剤
AP2007004162A0 (en) * 2005-02-23 2007-10-31 Avestha Gengraine Tech Pvt Ltd Plant extracts and methods and uses therefore

Also Published As

Publication number Publication date
IN2014MN02269A (enExample) 2015-07-24
MX2014012742A (es) 2015-04-08
US20150290265A1 (en) 2015-10-15
RU2014145931A (ru) 2016-06-20
SA113340494B1 (ar) 2015-12-24
EP2841080A4 (en) 2015-11-25
BR112014026326A2 (pt) 2017-06-27
NZ701133A (en) 2016-08-26
AU2013254329A1 (en) 2014-11-13
IL235317A0 (en) 2014-12-31
CA2870907A1 (en) 2013-10-31
EP2841080A1 (en) 2015-03-04
WO2013160811A1 (en) 2013-10-31
KR20150003862A (ko) 2015-01-09
JP2015514797A (ja) 2015-05-21
CN104244962A (zh) 2014-12-24

Similar Documents

Publication Publication Date Title
CA2870907A1 (en) Composition for treating metabolic disorders
Liu et al. An in vivo and in vitro assessment of the anti-inflammatory, antinociceptive, and immunomodulatory activities of Clematis terniflora DC. extract, participation of aurantiamide acetate
JP3940928B2 (ja) Ｓｏｌａｎｕｍ属の植物由来の水溶性抽出物およびそれらの調製方法、ならびに水溶性抽出物を含む薬学的組成物
WO2021203614A1 (zh) 一种治疗冠状病毒性疾病的药物组合物及其制备方法和用途
CA2555296A1 (en) Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation of ppr-gamma receptors
US8080264B2 (en) Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
JP2017529344A (ja) ボタンの根皮、アンジェリカ・ダフリカの根、及びミシマサイコの根又はそれらの画分を有効成分として含有する神経変性障害の治療及び予防のための医薬組成物
CN101513426B (zh) 大花鸡肉参酯甲(+)2-(1-羟基-4-氧代环己基)咖啡酸乙酯化合物及其在制备白三烯a4水解酶功能调节药物中的应用
CN110251524A (zh) 化合物党参炔苷(Lobetyolin)的制备方法及在药物和保健品中的新用途
CN104474029A (zh) 欧洲白蜡树种子提取物及其治疗应用
Vikhe et al. Antidiabetic and antihyperlipidemic effects of crude fractions and isolated compound from Striga orobanchioides Benth on streptozotocin induced diabetic rats
Yu et al. Secondary metabolites of petri-dish cultured Antrodia camphorata and their hepatoprotective activities against alcohol-induced liver injury in mice
CN103961379B (zh) 一种硫磺菌提取物及用途
JP6758799B2 (ja) 医薬組成物
CN113637021A (zh) 一种活性化合物及其提取方法和应用、药物组合物及其应用
AU2013233930A1 (en) Herbal composition for the treatment of metabolic disorders
CN103301179B (zh) 杜仲木脂素提取物在制备用于防治高甘油三脂血症的药物中的应用
CN111150740A (zh) 竹节参中的降脂活性成分和降脂组合物及其应用
CN114736182A (zh) 一种抗心肌缺血再灌注损伤的化合物和傣药组合物及其应用
KR100697235B1 (ko) 관동화 추출물 또는 투실라곤을 포함하는 비만 및 제2형당뇨병 예방 및 치료용 조성물
AU3893500A (en) Inflammatory mediation obtained from atractylodes lancea
Kushwaha et al. Hepatoprotective activity of ethanolic extract of Euphorbia royleana linn in carbon tetrachloride treated guinea pig
Ogar et al. Effect of Ethanol and N-Hexane Combined Extracts of Selected Plants on Liver Enzymes in Wistar Rats: http://www. doi. org/10.26538/tjpps/v2i4. 4
PT1508334E (pt) Extracto solúvel em água a partir de planta do género solanum e o seu processo de preparação, e composição farmacêutica contendo o extracto solúvel em água
Nagar Hepatoprotective effects of Cyathula Prostrata Linn. in paracetamol induced liver injury in rats